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ABSTRACT
The c-Jun dimerization protein 2, JDP2, is a member
of the activating protein 1 (AP-1) family of transcrip-
tion factors. Overexpression of JDP2 has been
shown to result in repression of AP-1-dependent
transcription and inhibition of cellular transforma-
tion. Other studies suggested that JDP2 may func-
tion as an oncogene. Here we describe the
identification of CHOP10, a member of the CCAAT
enhancer binding proteins, as a protein associating
with JDP2. In contrast to the inhibition of transcrip-
tion by JDP2, JDP2–CHOP complex strongly
enhances transcription from promoters containing
TPA response elements (TRE), but not from those
containing cyclic AMP response elements (CRE).
The association between JDP2 and CHOP10 involves
the leucine zipper motifs of both proteins, whereas,
the basic domain of CHOP10 contributes to the
association of the JDP2–CHOP10 complex with the
DNA. DNA binding of JDP2–CHOP complex is
observed both in vitro and in vivo. Finally, over-
expression of JDP2 results in increased cell viability
following ER stress and counteracts CHOP10 pro-
apoptotic activity. JDP2 expression may determine
the threshold for cell sensitivity to ER stress. This is
the first report describing TRE-dependent activation
of transcription by JDP2 and thus may provide an
explanation for the as yet unexplored oncogenic
properties of JDP2.
INTRODUCTION
The basic leucine zipper (bZIP) transcription factors
form a large protein family that consists of several sub-
groups. They share a basic region that is responsible for
speciﬁc DNA binding, and a leucine zipper domain that
forms a coiled-coil structure and regulates protein
oligomerization, stability and speciﬁcity (1). The activat-
ing protein 1 (AP-1) group forms one branch of the bZIP
super family, and is composed of the Jun, Fos, activating
transcription factor (ATF) and MAF sub-family mem-
bers. The members of the AP-1 family are able to form
multiple unique combinations of homo-/heterodimers that
mediate the regulation of diﬀerent genes. AP-1 is an
immediate early transcription factor that responds to a
plethora of physiological and pathological stimuli, and it
has a crucial role in a variety of cellular events. The Jun
and ATF proteins form stable homo- and heterodimers,
while Fos proteins cannot homodimerize but can form
stable heterodimers with Jun family members. The
abundance of AP-1 subunits and the composition vary
greatly between diﬀerent cell types (2). The CCAAT
enhancer binding proteins (C/EBPs), of which there are
seven, are members of the bZIP family. They form dimers
both with other C/EBPs and with members of other bZIP
families, such as the AP-1 (1,3,4).
c-Jun dimerization protein 2 (JDP2) is a bona ﬁde
member of the AP-1 family that was isolated because of its
ability to interact with c-Jun (5) and ATF2 (6). JDP2
encodes an 18-kDa protein that is able to homodimerize,
as well as to form heterodimers with other AP-1 members,
such as c-Jun, JunB, JunD and ATF2, and a member of
the C/EBP family, C/EBPg (7). JDP2 is a repressor of
AP-1 protein family (5). The mechanism by which JDP2
represses AP-1 transcription involves competition for
DNA binding, inactive heterodimer formation (5), indirect
recruitment of histone deacetylase 3 (8), nucleosome
assembly activity (9), inhibition of histone acetylation (9)
and potential competition with JNK phosphorylation
(10,11). JDP2 has been shown to play a role in the cellular
diﬀerentiation of skeletal muscle (12), osteoclasts (13),
adipocytes (14) and F9 cells (8).
JDP2 is most closely related to ATF3, a member of the
ATF/CREB (CRE-binding protein) subfamily of the AP-1
group (15). ATF3 is a stress inducible gene: as its mRNA
level greatly increases upon exposure of cells to stress
signals (15). ATF3 has been reported to activate tran-
scription as a heterodimer with c-Jun, whereas it represses
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CHOP10/GADD153 (referred as CHOP10 for simplicity),
a member of the C/EBP family, to form a nonfunctional
complex (17). JDP2 and ATF3 exhibit 61% overall
homology. While the bZIP domains of these two proteins
show 90% homology, outside the bZIP domain JDP2 and
ATF3 display very low similarity. Both JDP2 and ATF3
bind to TRE as well as to CRE DNA elements in vitro.
It has recently been shown in our laboratory (18) that
transgenic mice with temporal cardiac expression of JDP2
exhibit a similar phenotype to ATF3 transgenic mice (19).
This suggests that these two proteins have a similar role in
the heart (18,20). Despite the high degree of similarity in
this aspect, there appear to be considerable diﬀerences
between JDP2 and ATF3 with regard to their regulation.
JDP2 is ubiquitously expressed and its level remains
unchanged following various stimuli (10). Nevertheless,
in a number of processes, such as diﬀerentiation of skeletal
muscle cells (12), osteoclasts (13) and ultraviolet irradia-
tion (21), a modest increase in JDP2 expression is
observed. JDP2 undergoes phosphorylation by c-Jun
N-terminal kinase (JNK) and p38 kinase on threonine
148, but the precise role of this phosphorylation in terms
of its biological function is currently unknown (10,11).
Diﬀerent studies suggest that JDP2 has a dual role in
malignant transformation. On the one hand, it is well
established that JDP2 eﬃciently counteracts AP-1 tran-
scription (5), and thus may interfere with the oncogenic
properties of c-Jun. JDP2 has been found to inhibit cell
transformation induced by Ras in vitro and in xenografts
injected into SCID mice (22). On the other hand, JDP2
has been identiﬁed as a candidate oncogene in a high-
throughput screen based on viral insertional mutagenesis
in wild-type mice (23). It has also been associated to
potentiate multicentric lymphogenesis in collaboration
with either a loss of function mutation of p27 (24) or with
the overexpression of c-Myc and Runx2 oncogenes (25).
In the present study, we identiﬁed CHOP10 as a novel
protein partner for JDP2. We have shown for the ﬁrst time
that the repression of TRE-containing promoters by JDP2
may be switched to strong transcription activation by the
association of JDP2 with CHOP10. The leucine zipper
domain of CHOP10 is necessary for its association with
JDP2, and the basic region of CHOP10 plays a role in
mediating the binding of the complex to the TRE DNA
sequences. JDP2 counteracts the pro-apoptotic activity
of CHOP10 and thus provides increased cell resistance
to endoplasmic reticulum (ER) stress. The recruitment of
CHOP10 to TRE containing promoters resulting in the
potentiation of transcription, may provide a molecular
basis for the role of JDP2 as a tumor promoter.
MATERIALS AND METHODS
Antibodies and reagents
Thapsigargin was purchased from Sigma–Aldrich Ltd.
(cat# T9033) and was dissolved in DMSO to generate a
1mM stock solution. Antibodies against JDP2 were used
as described (5). Polyclonal antibodies directed against:
CHOP10, c-Jun and THTR1 were purchased from
Santa Cruz. Monoclonal antibodies against: hemaggluti-
nin (HA) (12CA5) from Babco Inc, CHOP10 (9C8) from
Abcam Inc., a-tubulin from Sigma–Aldrich Ltd.
Plasmids
The expression plasmids encoding wild-type CHOP10
and the CHOPLZ mutant were kindly donated by
Prof. David Ron (Skirball Institute, NY, USA) (26).
CHOPBasic was generated using a site-directed muta-
genesis kit (Stratagene Inc.), using appropriate oligonu-
cleotides to generate a deletion of the entire basic domain
sequences encoding amino acids 101–122. The deletion
was conﬁrmed by DNA sequencing.
The expression plasmid pcDNA 3.1 (Invitrogen Inc.)
was used to express His-JDP2. JDP2 fused to HA
(HA-JDP2) was expressed using the pCEFL expression
plasmid, which was kindly donated by Dr SJ Gutkind
(NIH, Bethesda, MD, USA). CyCD1-Luciferase reporter
plasmid (27) was kindly donated by Dr Richard G. Pestell
(Thomas Jeﬀerson University, Philadelphia).
Tethered dimers were cloned into a His tag-containing
pcDNAc expression plasmid (Invitrogen Inc.) in the
following manner. A BamHI–EcoRI double-stranded
oligonucleotide linker encoding a polypeptide linker
(50-GGA TCC GGG GGA TCA GGC GGA GGT
GGA GGT TCC GGT GGC GGT GGC GAA TTC-30)
was introduced into a BamHI–EcoRI linearized pcDNAc-
His vector. PCR fragments encoding for JDP2 and CHOP
were generated using appropriate speciﬁc oligonucleo-
tides. A 50 BamHI site was generated for JDP2, together
with a BglII site at the 30 end that included the complete
coding region but avoided the JDP2 stop codon. In
addition, a CHOP10 DNA fragment was designed to
harbor an in-frame EcoRI site at the 50-end, and an XhoI
site was designed at the 30 end of the complete coding
sequence.
Ras recruitment system and yeast manipulations
Conventional yeast transfection and manipulations were
performed as previously described (28). The interaction
of CHOP10 with JDP2-LZ and ATF3 was examined
by mating. Cdc25-2a, and a haploid yeast strains were
transfected with the pMyr (uracil selectable marker) and
Bait (leucine selectable marker) expression plasmids.
Transformants were selected and grown on glucose-
containing plates that lacked either uracil or leucine.
Mating was performed on YPD plates overnight at 248C.
Following mating, colonies were replica plated on to
plates that lacked uracil and leucine to select for diploid
transformants and incubated at 248C. Subsequently,
colonies were replica plated on to galactose plates that
lacked methionine to induce the expression of the prey and
bait proteins. Plates were incubated at 368C to test for
Ras-Bait membrane translocation and complementation
of the Cdc25-2 temperature-sensitive phenotype.
Cellculture andtransfections
Mouse ﬁbroblast cells (NIH3T3) were grown in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 4.5g/ml D-glucose containing 10% fetal
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5% CO2 incubator.
Stable NIH3T3 cell lines were generated by retroviral
infection using a pBabe vehicle, pBabe-JDP2 and pBabe-
CHOP10 expression plasmids as previously described (22).
Following infection, colonies were selected using 2mg/ml
puromycin.
For the luciferase reporter assays, cells were grown in
60-mm dishes (2.5 10
5 cells/dish) and were transfected
the following day using the X-TremeGENE Q2 transfec-
tion reagent (Roche Inc.).
For the co-immunoprecipitation assay, NIH3T3 cells
were transfected with the jetPEI transfection reagent
(Polyplus transfection Inc.), following the manufacturer’s
protocol; 7mg of DNA and 14ml of reagent were used for
each 100-mm plate.
SV40 large T antigen immortalized mouse embryo
ﬁbroblasts (MEF) corresponding to parental and
CHOP10
 /  cell lines were kindly provided by Prof.
David Ron (Skirball Institute, NY, USA) (29). These cells
were used for retroviral infection as described above to
produce stable cell lines expressing JDP2, CHOP10 and
JDP2-CHOP chimera.
Reporter assays
NIH3T3 cells were co-transfected with expression plas-
mids and reporter plasmids, using the X-TremeGENE Q2
transfection reagent (Roche) and following the manufac-
turer’s protocol; 3mg of DNA and 7.5ml of reagent were
used for each 60-mm plate. Twenty-four hours after
transfection, cells were harvested and tested for luciferase
activity using the Luciferase Assay System (Promega
Corp.) as described in the manufacturer’s protocol.
Nuclear extraction was performed as previously
described (30), except that the buﬀers included Protease
Inhibitor Cocktail (Sigma–Aldrich Inc.).
Westernblot
Western blot analysis was performed in 5% nonfat dry
milk (Carnation); washes were performed with PBS.
Polyclonal antibodies against JDP2 were used at a dilution
of 1:500; polyclonal antibodies against CHOP10; and
c-Jun were used at a 1:200 dilution. Monoclonal anti-
a-tubulin was used at a 1:5000 dilution. Secondary HRP-
conjugated antibodies directed against rabbit and mouse
antigens were purchased from Sigma–Aldrich Inc.
Co-immunoprecipitation
Protein-A Sepharose beads (Sigma–Aldrich Inc.) were
preincubated with antibodies against either HA or JDP2.
Following two washes with PBS and one wash with the
nuclear extraction buﬀer, 200 or 900mg of the nuclear
extract were added to the beads, which were then
incubated overnight at 48C. Following three washes with
the nuclear extraction buﬀer, the precipitated proteins
were eluted using SDS–PAGE sample buﬀer. Samples
were boiled and then separated by 12.5% SDS–PAGE
followed by western blot analysis.
Electromobility shift assay(EMSA)
In vitro translated rabbit reticulocyte lysate (3ml) was used
to bind Jun-TRE
32P-labeled double-stranded oligonu-
cleotides in binding buﬀer (20mM Tris pH 7.5, 0.5mM
EDTA, 0.5mM DTT, 10% glycerol, 70mM NaCl, unless
otherwise indicated) containing 1mg poly(dI–dC). The
sequence of the double-stranded Jun-TRE site (the core
TRE site is underlined) used was: TTCGGGGTGACA
TCATGGGCTAT
A 6% nondenaturing gel was used to separate bound
and free probe in 0.5  TBE. The gel was dried and
exposed to autoradiography for 16h.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assays were
performed using ChIP assay kit (Upstate Millipore)
according to the manufacturer’s instructions. In principle,
NIH stable cell lines were transfected with the indicated
combination of reporter plasmid and expression vector.
Twenty-four hours following transfection cells were cross-
linked with formaldehyde lyzed and sonicated on ice for
eight cycles of 5s each with 30s intervals. This resulted
DNA fragmentation to an average length of 500–1000bp.
Immunoprecipitation was performed with either nonrele-
vant serum (anti-THTR1 SC#27656) or anti-CHOP10
polyclonal antibodies (SC#575) both were purchased from
Santa Cruz. Precipitated protein–DNA complexes were
extensively washed according to the manufacturer’s
instructions. Cross-link was reversed by addition NaCl
to ﬁnal concentration 200mM for 4h at 658C. DNA was
phenol–chlorophorm extracted and ethanol precipitated.
PCR was performed with the following oligonucleotides
corresponding to a 200-bp DNA fragment adjacent to the
Jun TRE element located at the  79 position of the
human c-Jun reporter plasmid. Top-primer 50-TCATGT
CTGGATCCAAGCTTC bottom-primer 50- GCAGTTC
GGACTATACTGCC. PCR reaction was performed with
23 cycles and 638C annealing temperature.
Oligonucleotides corresponding to the luciferase coding
region located 1000-bp downstream to the luciferase
translation start site top-primer 50-CAGGTATCAGGC
AAGGATATGG and bottom-primer 50- GAGACTTC
AGGCGGTCAACGA designed to generate a 320-bp
PCR fragment. PCR reaction was performed with 30
cycles and 628C annealing temperature.
Cell viability assays
Cell viability assays were performed using a CellTiter-
GloTM luminescent cell viability assay kit (Promega
Corp.). The kit is a homogeneous method of determining
the number of viable cells in culture based on luminescent
assay directed toward ATP content determination. The
assay was performed according to the manufacturer’s
instructions, with small modiﬁcations. Brieﬂy, 24h follow-
ing the addition of thapsigargin the medium was removed.
The lysis-luminescent reagent diluted 1:1 with PBS was
applied directly onto the cells. Luminescence was mea-
sured using an IVIS-200 and analyzed using Igor pro
version 2.5 (Xenogen Inc.).
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Identification ofCHOP10 asaJDP2-associated protein
using the Ras recruitment system
To identify proteins that interact with JDP2, we used the
Ras recruitment system (RRS) (7). In principle, a bait
protein was designed that comprised the JDP2 leucine
zipper domain fused to the C-terminus of cytoplasmic Ras
(Ras-JDP2-LZ). The bait was used to screen a pMyr-
based HeLa cDNA expression library (Stratagene Inc.).
Fifty-three yeast colonies were selected and the prey DNA
expression plasmids were isolated and reintroduced into
Cdc25-2 yeast strain together with either nonrelevant bait
or the original Ras-JDP2-LZ bait. 47 clones displayed
bait-speciﬁc growth at the restrictive temperature.
Sequence analysis of the plasmids revealed the isolation
of novel JDP2-interacting partners among them; members
of the basic leucine zipper family such as ATF4 and
CHOP10, transcription regulators such as HDAC6, as
well as known interacting proteins such as C/EBPg (7).
The current study focuses on CHOP10 protein interaction
with JDP2. CHOP10, which is also known as GADD153
will be referred to hereafter as CHOP10. To verify that
CHOP10 interacted speciﬁcally with JDP2, yeast cells
were used to co-express diﬀerent baits with the CHOP10
prey. The prey protein used was membrane-anchored
CHOP10 (M-CHOP); whereas an empty expression
plasmid (pMyr) was used as a control. Yeast transfor-
mants that co-expressed the bait Ras-JDP2-LZ together
with membrane-anchored CHOP10 displayed eﬃcient
growth at the restrictive temperature, 368C (Figure 1).
JDP2 and ATF3 display a high degree of identity within
the bZIP domain, and an association between ATF3 and
CHOP10 has already been shown (17). Indeed, we were
able to recapitulate the association of the bait encoding
the full-length ATF3 fused to the cytoplasmic Ras (Ras-
ATF3) with the membrane-associated CHOP10 prey using
the RRS (Figure 1).
JDP2–CHOP interaction in mammalian cells
To validate the interaction between CHOP10 and JDP2 in
a diﬀerent cell environment, we used a modiﬁed mamma-
lian two-hybrid approach. NIH3T3 cells were transfected
with plasmids encoding the full-length JDP2 protein fused
to the yeast GAL4 DNA-binding domain (GAL4-DBD-
JDP2) in the presence or absence of an expression plasmid
that encoded CHOP10. A reporter plasmid was also
included to drive the expression of a luciferase reporter
gene under the control of ﬁve copies of the upstream-
activated sequence (UAS) that corresponds to the GAL4
DNA-binding site. Because CHOP10 harbors a potent
intrinsic activation domain at its N-terminus, it was not
necessary to fuse CHOP10 to the GAL4 activation
domain. We hypothesized that the interaction between
CHOP10 and Gal4-DBD-JDP2 would be suﬃcient for the
formation of a functional GAL4 transcription activator,
and would lead to transcriptional activation of the
5 UAS luciferase reporter gene.
Twenty-four hours following transfection, cells were
harvested and luciferase activity was determined. The
expression of GAL4-DBD-JDP2 resulted in very low
basal transcription activity, which was even lower
than that obtained with GAL4-DBD alone. This demon-
strated the ability of JDP2 to repress transcription even
when fused to a heterologous DNA-binding domain.
Co-expression of Gal4-DBD-JDP2 with CHOP10 resulted
in potentiation of the transcription activity of the reporter
gene by 25-fold (Figure 2). This eﬀect strongly conﬁrms
the speciﬁc association between full-length JDP2 and
CHOP10 in mammalian cells (Figure 2). Because the
original JDP2 bait used to isolate CHOP10 encoded
the JDP2 leucine zipper domain, we were interested in
examining which domain within CHOP10 is responsible
for association with JDP2. We used the mammalian
two-hybrid system to map the domains within CHOP10
that are responsible for its association with JDP2.
Two expression plasmids encoding CHOP10 mutants,
which lacked either the basic domain (CHOPBasic)
or the leucine zipper domain (CHOPLZ), were used.
Transfection of the CHOP10 mutant that lacked the
basic domain resulted in luciferase activity similar to that
of the wild-type CHOP10 protein, whereas the CHOP10
mutant that lacked the leucine zipper domain failed to
stimulate transcription of the 5 UAS luciferase reporter
gene (Figure 2). Together, these data suggest that the
association of JDP2 with CHOP10 is mediated by the
leucine zipper domain of both proteins and that the basic
domain of CHOP10 does not contribute to its association
with JDP2.
JDP2and CHOP10 co-immunoprecipitation
To demonstrate a direct association between JDP2 and
CHOP10, we used a co-immunoprecipitation approach.
NIH3T3 cells were transiently transfected with an
pMyr
pMyr-CHOP
Ras-Pak
Ras-Pak
pMyr Ras-JDP2-LZ
Ras-JDP2-LZ pMyr-CHOP
Ras-ATF3 pMyr
pMyr-CHOP Ras-ATF3
pMyr Bait
Figure 1. Identiﬁcation of the JDP2–CHOP association in yeast using
the RRS. Yeast diploid transformants expressing the indicated prey and
bait proteins were selected and grown on glucose plates lacking both
uracil and leucine. Colonies were grown at 248C for 2 days and subse-
quently were replica plated onto galactose plates lacking methionine,
leucine and uracil, and grown at 368C. The baits fused to Ras are: the
p21 activating kinase regulatory domain (Ras-Pak), the JDP2 leucine
zipper domain (Ras-JDP2-LZ) and full-length ATF3. An empty pMyr
expression vector or human CHOP10 fused to v-Src myristoylation
signal (pMyr-CHOP10) were used as prey proteins.
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(HA) JDP2 (HA-JDP2), or an empty HA-tagged expres-
sion vector plasmid. To induce endogenous expression of
CHOP10, we used thapsigargin (Tg), an inhibitor of sarco
ER Ca
+2 ATPase (SERCA), which is known to induce ER
stress and results in increased expression of CHOP10
(31,32). HA-JDP2 was immunoprecipitated using an
antibody against the HA-tag and nuclear extracts derived
from either untreated cells or cells exposed to 400nM Tg
for diﬀerent time periods. Precipitated proteins, together
with the total input lysate, were separated by 12.5%
SDS–PAGE, and transferred to nitrocellulose membranes.
Membranes were probed sequentially with antibodies
against JDP2, CHOP10 and c-Jun.
The level of endogenous expression of CHOP10 was
increased considerably in the total cell lysates derived
from cells exposed to Tg; the increase was related to the
duration of exposure (Figure 3A). c-Jun expression level is
slightly elevated during the ﬁrst few hours following
exposure to Tg while remained constant thereafter.
In contrast, the level of the transfected HA-JDP2 was
not signiﬁcantly changed following Tg treatment.
Following immuprecipitation with anti-HA antibody,
both CHOP10 and c-Jun were not precipitated by the
antibody against the HA-tag in the vector control lysate,
eﬃcient precipitation was observed for both c-Jun and
CHOP10 with cell lysates derived from HA-JDP2
transfected cells (Figure 3B). The amount of CHOP10
protein that co-precipitated with the antibodies against the
HA-tag gradually increased with the time of exposure to
ER stress, and attained its highest level at 16h following
Tg treatment (Figure 3B, middle panel). This is consistent
with the elevation in CHOP10 expression levels that
occurred with increased duration of exposure to Tg.
In contrast, precipitation of c-Jun was reduced in an
inverse relationship with the duration of exposure to Tg
(Figure 3B, bottom panel). The increase in the level of
precipitated CHOP10 protein, in parallel with the decrease
in precipitated c-Jun (starting 3h following Tg treatment),
suggests that part of the association of JDP2 with
CHOP10 that follows ER stress may be formed by
replacement of the pre-existing JDP2-c-Jun heterodimers.
The fact that transfected HA-JDP2 was able to precip-
itate endogenous CHOP10 protein prompted us to
examine the interaction between the endogenous JDP2
and CHOP10 proteins. NIH3T3 cells were treated for
16h with 400 nM Tg to induce expression of CHOP10.
Pre-cleared nuclear extracts derived from treated and
untreated cells were used for immunoprecipitation
with antibodies against either THTR1 (NR) or JDP2.
WB:JDP2
HA HA-JDP2
t(Tg,hr) 16 16 036 2 3
WB:CHOP
WB:c-Jun
A
WB:JDP2
C
IP:aHA
WB:JDP2
WB:CHOP
WB:c-Jun
B
HA HA-JDP2
16 16 036 2 3
t(Tg,hr) 0 16 0 16 0 16
WB:CHOP
Total IP:aNR IP:aJDP2
12 3 4 5 6
12 3 4 5 6
12 3 4 56
t(Tg,hr)
Figure 3. JDP2 interacts with endogenous CHOP10 in Tg-stressed cells.
NIH3T3 cells were transfected with pCEFL expression plasmids
encoding HA-tagged JDP2 (HA-JDP2), or the empty vector (HA).
For the induction of CHOP10 expression, transfected cells were
exposed to 400nM Tg for the indicated time. Nuclear extracts were
used for immunoprecipitation with antibodies against the HA-tag.
Western blots of 10% of the total input lysates (A) and precipitated
proteins (B) were probed with the indicated antibodies. (C) NIH3T3
cells were either not treated or exposed to 400nM Tg for 16h. Nuclear
extracts were precleared with a nonrelevant (aNR) polyclonal antibody
(lanes 3 and 4), and subsequently an antibody against JDP2 was
used for immunoprecipitation (lanes 5 and 6). Western blots of 5% of
the total input lysates (lanes 1 and 2) and precipitated proteins using
the indicated antibody are shown. Antibodies used were: anti-JDP2,
mouse anti-CHOP10 and rabbit anti-c-Jun.
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Figure 2. Validation of the CHOP and JDP2 interaction using the
mammalian two-hybrid system. NIH3T3 cells were co-transfected with
expression plasmids encoding either the Gal4 DBD or Gal4 fused to
JDP2 (Gal4DBD-JDP2), together with a luciferase reporter gene under
the control of ﬁve tandem repeats of the Gal4 DNA binding site
(UAS), in the presence or absence of plasmids coding for either
wild-type CHOP10 or the indicated CHOP10 mutant. CHOP10
mutants either lacked the leucine zipper domain (34) (CHOPLZ) or
lacked 23 amino acids corresponding to the CHOP10 basic region
(CHOPBasic). The luciferase activity obtained with the empty expres-
sion vector was designated 1, and all other activities were calculated
relative to this. The net eﬀect of CHOP10 on Gal4DBD-JDP2 was
calculated. The results represent the mean SEM of four independent
experiments.
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lysate, were separated by 12.5% SDS–PAGE, and
transferred to nitrocellulose ﬁlters. Membranes were
probed with antibodies against either JDP2 or CHOP10.
JDP2 expression levels remained unchanged in the total
nuclear cell lysate derived from cells that were either
untreated or treated with Tg. Consistently, CHOP10
expression level was signiﬁcantly increased following Tg
treatment (Figure 3C). Immunoprecipitation with the
nonrelevant antibody did not result in precipitation of
either CHOP10 or JDP2 proteins. In contrast, anti-JDP2
antibodies eﬃciently precipitated JDP2 in both cell
lysates (Figure 3C). Signiﬁcantly, CHOP10 was eﬃciently
co-precipitated by the JDP2-antibody only in nuclear cell
lysate that was derived from cells that had been induced
by Tg for 16h (Figure 3C).
TRE-dependent transcription activation
by JDP2–CHOP complex
To investigate the eﬀect of CHOP10 on JDP2-induced
transcription from diﬀerent TRE and CRE sequences,
NIH3T3 cells were co-transfected with plasmids encoding
JDP2 and CHOP10 in diﬀerent combinations, together
with luciferase reporter plasmids that were under
the control of diﬀerent promoters known to harbor
TRE/CRE DNA-binding elements. The promoters used
for the reporter genes included a  1745 to +14bp
sequence derived from the cyclin D1 promoter (CycD1-
luc),  79 to +170bp derived from the human c-Jun
promoter ( 79-Jun-luc),  73 to +63bp derived from the
human collagenase promoter ( 73-hCol-luc) and a
synthetic CRE-pTAL luciferase reporter plasmid (CRE-
luc, BD Bioscience Ltd.). Twenty-four hours following
transfection, cells were harvested and luciferase activity
was determined.
The transfection of either JDP2 or CHOP10 separately
resulted in inhibition of transcription activity or a very
minor eﬀect on all the luciferase reporter plasmids exam-
ined. In contrast, the co-expression of CHOP10 with JDP2
resulted in strongly synergistically enhanced transcription
of the CycD1,  79-Jun-luc and  73-hCol-luc sequences.
The CRE-luciferase reporter plasmid showed only a mild
additive eﬀect of the proteins (Figure 4A). This result
strongly suggests that the JDP2–CHOP complex potently
enhances the transcriptional capability of both proteins;
this eﬀect is speciﬁc for promoters that contain a TRE and
does not aﬀect CRE-dependent promoters.
A previous report has demonstrated that the association
of ATF3 and CHOP10 impairs the binding and repression
activity of ATF3 towards CRE DNA-binding sequences
(17). To examine the transcription capability of the ATF3-
CHOP heterodimer, NIH3T3 cells were co-transfected
with diﬀerent combinations of plasmids encoding ATF3
and CHOP10 together with various luciferase reporter
plasmids. Similar to the eﬀect of JDP2, the co-expression
of CHOP10 and ATF3 resulted in potentiation of the Jun,
collagenase and cyclin D1 reporter plasmids, but consis-
tent with the previous report (17), no signiﬁcant increase
in transcription was observed with the CRE luciferase
reporter (Figure 4A).
To examine whether or not the JDP2-CHOP complex
displays a distinct DNA-binding speciﬁcity from that of
the JDP2 homodimer, we investigated the transcription
capability of JDP2 fused to a strong activation domain
derived from the herpes simplex virus protein VP16
(VP16-JDP2). The fusion of a strong activation domain
is dominant over JDP2 repression activity turning JDP2
into strong transcriptional activator while preserving
JDP2 DNA binding speciﬁcity (21).
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Figure 4. The CHOP–JDP2 interaction strongly potentiates TRE- but
not CRE-dependent transcription. (A) NIH3T3 cells were co-transfected
with the indicated expression plasmids (1mg each) together with the
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based Rat JDP2 (JDP2), human CHOP10 (CHOP), human ATF3
(ATF3) and JDP2 fused to the VP16 activation domain (VP16-JDP2). In
transfections in which a single expression plasmid was used the total
amount of expression plasmid was adjusted with the corresponding
pcDNA empty expression vehicle. Reporters used were: CRE-luc,
cyclic AMP response element; CycD-luc,  1850 cyclin D1 promoter;
 79-Jun-luc,  79 c-Jun promoter;  73-hCol-luc,  73 collagenase
promoter. Luciferase activity was determined and the results represent
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with antibodies against CHOP10. Lane 1 represents JDP2-transfected
cells in the absence of CHOP10 expression.
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plasmid and the diﬀerent luciferase reporter plasmids.
Luciferase activity measured 24h following transfection
revealed that VP16-JDP2 was able to potentiate transcrip-
tion eﬃciently from all the TRE and CRE reporter plas-
mids tested. Surprisingly, the CRE-luc reporter exhibited
the most distinguishable activity. Whereas the JDP2–
CHOP complex was only able to activate transcription
from the CRE-luc reporter plasmid by a factor of two, it
exhibited a signiﬁcantly more potent transcription activity
with the VP16-JDP2 protein (a 50-fold increase). Thus we
conclude that JDP2–CHOP complex displays an altered
DNA-binding speciﬁcity as compared with the JDP2
homodimer.
To test whether the association between JDP2 and
CHOP10 is required for the potentiation of transcription
from TRE-responsive promoters, NIH3T3 cells were
co-transfected with increasing amounts of expression
plasmids encoding either wild-type CHOP10 or a
CHOP10 mutant that lacked the leucine zipper domain
(CHOPLZ), together with a constant level of JDP2.
Whereas the wild-type CHOP10 activated the  79-Jun-luc
reporter in a dose-dependent manner, the addition
of CHOPLZ failed to result in any signiﬁcant altera-
tion in the  79-Jun-luc reporter transcription activity
(Figure 4B). Western blot analysis using cell lysates derived
from the transfected cells revealed that both the wild-type
CHOP10 and CHOPLZ proteins are expressed at similar
levels (Figure 4B, bottom panels). Therefore, expression
level diﬀerences cannot provide an explanation for the
inability of the CHOPLZ to increase JDP2-TRE-
dependent transcription. Collectively the above results
strongly suggest that the leucine zipper domain of
CHOP10 is necessary for the JDP2-CHOP association
(Figure 2) and for the potentiation of transcription.
Atethered JDP2–CHOP chimera activates transcription
fromTRE-containing promoters
We hypothesized that the association between CHOP10
and JDP2 results in the generation of a complex that
activates transcription. To study the speciﬁcity of binding
to the promoter element at an optimal stoichiometric
ratio, single chain dimers were generated in which
CHOP10 was fused in frame with JDP2 via a ﬂexible
polypeptide linker (JDP2–CHOP). In addition, relevant
monomer controls were designed (Figure 5A). JDP2–
CHOP chimera force speciﬁc intramolecular pairing to
occur that is expected to reduce the associations with
other bZIP proteins in the cell, as well as to decrease the
chances of homodimerization of the overexpressed pro-
teins (33). Thus the use of leucine zipper chimera provides
a reliable system to examine more directly the transcrip-
tion capability of diﬀerent pairs of proteins. To this end,
NIH3T3 cells were co-transfected with increasing amounts
of either the JDP2–CHOP chimera or the monomeric
components as controls (His-JDP2 and His-CHOP10),
together with plasmids encoding the luciferase reporter
gene driven by various promoter elements:  79-Jun, CRE,
or the CHOP10 site that corresponded to the CHOP10-
C/EBP speciﬁc binding site (34). Twenty-four hours
following transfection, cells were harvested and luciferase
activity was determined (Figure 5B).
As previously observed, single transfection with either
JDP2 or CHOP10 encoding plasmids repressed or
exhibited an insigniﬁcant eﬀect on transcription, respec-
tively, with the luciferase reporters containing the  79-Jun
and CRE sequences, as well as with the CHOP10-C/EBP
luciferase reporter plasmid. In addition, JDP2-CHOP
chimera consistently displayed a negligible eﬀect on
transcription of the CRE and the CHOP10-C/EBP site.
In contrast, the JDP2–CHOP chimera showed a signiﬁ-
cant dose-dependent transactivation of the  79-Jun-luc
reporter plasmid; it induced transcription by  20-fold
when 1mg of expression plasmid was used (Figure 5B).
These results are consistent with those obtained by tran-
sient co-transfection experiments with plasmids encoding
CHOP10 and JDP2 (Figure 4), indicating the reliability
of the tethered dimer method. The results strongly suggest
that the forced dimer JDP2–CHOP has the same bind-
ing selectivity and activates the transcription activity of
TRE-containing promoters. To examine the ability of
JDP2–CHOP to associate physically with the TRE DNA
site, we used in vitro translated protein products and an
EMSA with P
32-labeled Jun-TRE probe. Whereas unpro-
grammed reticulocyte lysate (Figure 5C) and CHOP10
(Figure 6B) displayed no binding to the Jun TRE probe,
JDP2 exhibited eﬃcient binding to the Jun TRE.
Interestingly, the JDP2–CHOP chimera displayed eﬃcient
binding to the Jun TRE probe at70mM NaCl, andshowed
signiﬁcantly slower migration compared with the JDP2-
JDP2 homodimer (Figure 5C). Optimal DNA-binding
activity of the in vitro translated JDP2 homodimer
occurred at 150mM NaCl. In addition, JDP2–CHOP
displayed altered DNA-binding speciﬁcity compared with
the JDP2 homodimer (data not shown). CHOP10 is unable
to directly associate with DNA as a homodimer due to the
presence of proline and glycine residues within the basic
domain (32).
JDP2–CHOP associates with DNA in vivo
To examine whether JDP2–CHOP interaction with the
Jun-TRE DNA also occurs in tissue culture cell lines, we
used ChIP assay with NIH3T3 cells stably transfected
with either CHOP10 or JDP2–CHOP chimera. The
expression level of CHOP10 and JDP2–CHOP proteins
in the NIH3T3 stable cell lines used for the assay relative
to the endogenous JDP2 expression level is shown
(Figure 5D). To increase the JDP2 level in NIH3T3-
CHOP10 cell line, cells were co-transfected with an
expression plasmid encoding for JDP2. Both cell lines
were transfected with the human –79-Jun luciferase
reporter plasmid. Twenty-four hours following transfec-
tion, cells were cross-linked with formaldehyde and DNA
was fragmented by sonication. Immunoprecipitation was
performed with either nonrelevant serum (anti-thiamine
transporter 1, THTR1) or with anti-CHOP10 polyclonal
antibodies. Following extensive washes cross-link was
reversed and DNA was extracted. The precipitated
puriﬁed DNA was used as template for a PCR reaction
with appropriate primers located 200bp adjacent to the
3614 Nucleic Acids Research, 2008, Vol. 36, No. 11Jun-TRE within the human Jun-luciferase promoter.
While no speciﬁc signal was obtained with DNA extracted
from immunoprecipitation with the nonrelevant antibody
following 20-25 PCR cycles (23 cycles are shown), the
DNA extracted following immunoprecipitation with the
anti-CHOP10 antibody resulted in a strong signal
corresponding to a DNA fragment of the expected size
(Figure 5E, top panel). To demonstrate that the
precipitated DNA is speciﬁc to the DNA sequence
adjacent the Jun-TRE element, we used oligonucleotides
corresponding to the luciferase coding region located
1200-bp downstream of the Jun-TRE site and performed a
PCR reaction using the precipitated DNA as template.
A 320-bp fragment was eﬃciently generated using either
10ng DNA plasmid corresponding to the Jun-luciferase
reporter or total DNA extracted directly from the
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Nucleic Acids Research, 2008, Vol. 36, No. 11 3615transfected cells. In contrast, no speciﬁc fragment was
observed with the precipitated DNA derived from the
immunoprecipitations performed with either the nonrele-
vant serum or the anti-CHOP10 (Figure 5E, bottom
panel). These results, strongly suggest that the JDP2–
CHOP complex was able to associate with the human Jun
promoter directly in NIH3T3 cells.
The CHOP10 basic domain iscrucial
fortranscription activation
The results shown in Figure 5 suggest that the JDP2–
CHOP complex exhibits altered DNA-binding speciﬁcity
as compared with the JDP2 homodimer. To examine
whether the CHOP10 basic domain may support DNA
binding of JDP2–CHOP and is crucial for transcription
activation, a JDP2–CHOP chimera was designed that
comprised JDP2 fused to a CHOP10 mutant protein
lacking the entire basic region (JDP2–CHOPBasic). The
transcription activity of the JDP2–CHOPBasic mutant
was tested with the  79-Jun luciferase reporter (Figure 6).
The JDP2–CHOPBasic chimera was unable to activ-
ate transcription of the  79-Jun luciferase reporter
(Figure 6A). Western blot analysis revealed that JDP2–
CHOPBasic is well expressed as compared with the
other JDP2–CHOP chimeras (Figure 6A, bottom panel).
Consistently, we used retic lysate programmed with
diﬀerent CHOP10 mutants lacking either the basic
domain or the leucine zipper domain in EMSA with
Jun-TRE. Although, the diﬀerent JDP2–CHOP mutants
were expressed to similar levels (Figure 6B, bottom), yet,
JDP2–CHOP lacking the basic domain displayed reduced
Jun-TRE binding (Figure 6B). In contrast, the JDP2–
CHOP chimera lacking the CHOP10 leucine zipper
domain showed potentiation of transcription similar to
that of the wild-type JDP2–CHOP chimera (Figure 6A).
In addition, the JDP2–CHOPLZ chimera exhibited
eﬃcient binding to the Jun TRE (Figure 6B, top panel),
suggesting that the forced dimerization was suﬃcient to
substitute for the leucine zipper domain and allowed the
basic domain to support DNA binding of the complex. To
ensure that the CHOP10 lacking the basic domain
preserves its ability to associate with JDP2, we tested the
interaction between JDP2 and CHOPBasic proteins.
Co-immunoprecipitation of HA-JDP2 with CHOPBasic
conﬁrmed that the basic region is not required for JDP2
binding (data not shown and Figure 2). Collectively, the
results suggest that the recruitment of CHOP10 to JDP2 is
not suﬃcient for transcription activation, and that the
basic domain of CHOP10 plays a role in the association of
the JDP2–CHOP dimer with the TRE-DNA-binding site.
This is in contrast to a situation previously described, in
which tethering of CHOP10 to pre-existing Jun–Fos
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3616 Nucleic Acids Research, 2008, Vol. 36, No. 11complexes was suﬃcient to enhance TRE transcription
(4). Indeed, CHOP10 was found to inhibit the transcrip-
tion activity of the C/EBP protein family by disrupting
their ability to bind DNA. Using a method that involved
selection of DNA-binding sites, a unique DNA-binding
site for CHOP10-C/EBP dimers and a CHOP10-depen-
dent stress-inducible target gene were identiﬁed (4,35).
In addition, previous reports have suggested that
CHOP10 downregulates ATF3 transcription repression
via the inhibition of ATF3 binding to various CRE and
ATF DNA elements (17). We observed that both JDP2–
CHOP and ATF3–CHOP complexes exhibit no signiﬁcant
eﬀect on the transcription of CRE-containing luciferase
reporter genes. However, in contrast, both JDP2–CHOP
and ATF3–CHOP complexes activated transcription from
TRE-containing reporter genes. Because the JDP2–CHOP
complex exhibited an altered DNA-binding speciﬁcity and
salt requirement in vitro (Figure 5C), we cannot exclude
the possibility that the JDP2–CHOP complex binds to a
novel DNA sequence yet to be identiﬁed.
Ectopic expression of JDP2 andCHOP10 alters
cell sensitivity to ERstress
CHOP10 is a transcription factor that is activated at
multiple levels during ER stress and is responsible for ER
stress-induced apoptosis (36). Cells in which CHOP10 has
been disrupted are more resistant to ER stress-induced
apoptosis. To investigate whether the JDP2–CHOP inter-
action may have some biological relevance, we generated
NIH3T3 cell lines that stably expressed either JDP2
(NIH3T3-JDP2) or CHOP10 (NIH3T3-CHOP). NIH3T3-
JDP2 expresses JDP2 to about 3-fold higher levels as
compared with vector transfected cells whereas, NIH3T3-
CHOP expressing cells expresses CHOP10 to about 2-fold
higher as compared with NIH3T3 cells exposed to 200nM
Tg for 6h (Figure 7A). Stably transfected NIH3T3 cells
were exposed to increasing concentrations of Tg for 24h,
and the viability of the cells was examined by measuring
the cellular ATP content. NIH3T3 cells with ectopic
expression of JDP2 displayed increased viability compared
with wild-type NIH3T3 cells (Figure 7B). In contrast,
NIH3T3 cells with CHOP10 overexpression displayed
increased sensitivity to Tg treatment. This result may
suggest that JDP2 functions to counteract the toxic eﬀect
of CHOP10 following ER stress. Alternatively, JDP2
over-expression may increase cell survival in a CHOP10-
independent manner. Indeed, previous work has suggested
that JDP2 is a cellular survival protein necessary for
normal cellular function (37). However, some recent study
demonstrating that JDP2 knockout mice are viable and
JDP2
 /  MEF exhibit no growth defect, strongly argues
against a role of JDP2 as a survival factor (14). To
distinguish between these two possibilities, we used SV40
large T antigen immortalized CHOP10
 /  MEF cells
exposed to diﬀerent concentrations of Tg. The expression
level of the diﬀerent stable cell lines used is shown
(Figure 7C). CHOP10
 /  MEF cells are more resistant to
Tg treatment as compared with the parental MEF cells
[(29) and Figure 7D]. In addition, CHOP10
 /  cells with
CHOP10 ectopic expression displayed sensitivity to Tg
treatment similar to wild-type MEF cells (Figure 7D).
Whereas JDP2 expressing cells exhibited increased resis-
tance to Tg treatment in NIH3T3 (Figure 7B) and in the
parental MEF cells (Figure 7D), JDP2 overexpression in
CHOP10
 /  MEF cells failed to alter the Tg sensitivity
(Figure 7D). Suggesting that the increase in Tg sensitivity
observed following JDP2 overexpression is CHOP10
dependent. To examine whether or not JDP2–CHOP
transcription complex is responsible for the transcription
of target genes (survival genes) that are responsible for the
increased resistance towards Tg treatment, we over-
expressed JDP2–CHOP chimera in the parental MEF
cells and examined their sensitivity to Tg. JDP2–CHOP
chimera expressing cells displayed similar sensitivity to Tg
treatment as compared with the parental MEF cells
(Figure 7D). Collectively, these results suggest that JDP2
protects cells from ER stress in a CHOP10-dependent
manner by counteracting CHOP10 toxic eﬀect. Yet, we
cannot exclude the possibility that JDP2 may have some
other beneﬁcial eﬀects acting as a homodimer or hetero-
dimer with CHOP10. Since JDP2 protein is constitutively
expressed at variable levels in all cells tested, the level of
JDP2 expression may play a role in determining the
cellular threshold response to ER stress-induced cell
death. In contrast, ATF3 is highly induced following ER
stress. ATF3 was shown to control CHOP transcription
and functions in a feedback inhibition of translation
control following ER stress by mediating GADD34
transcription (38). Our data may suggest that ATF3 is
able to cooperate with CHOP10 to result in increase in
GADD34 transcription. Both JDP2 (11) and CHOP10
(39) serve as substrates for the p38 kinase. The precise role
of JDP2 and CHOP10 phosphorylation following ER
stress is currently under investigation.
CONCLUSIONS
Here we described for the ﬁrst time the role of JDP2 in
TRE-dependent transcription activation. JDP2 associa-
tion with CHOP10 results in activation of transcription
from TRE but not CRE containing promoters. The basic
leucine zipper domain of both proteins is necessary for the
DNA binding and transcription activation. JDP2 expres-
sion counteracts CHOP10 pro-apoptotic activity and may
serve to set a threshold for ER response.
The role of JDP2 in carcinogenesis is controversial. On
the one hand, JDP2 inhibits TRE-dependent transcription
and inhibits NIH3T3 cell transformation by activated
Ras, H-Ras
V12 (22). On the other hand, JDP2 has been
found, during screening by insertional mutagenesis, to be
an oncogene cooperating with cMyc and the cell cycle
inhibitor p27 (23–25). The ability of JDP2 to associate
with CHOP10, resulting in transcription activation of
TRE-responsive genes, may explain this discrepancy. For
example, the cyclin D1 promoter has been shown to be a
direct target for JDP2 regulation (12). Indeed, both VP16-
JDP2 and JDP2-CHOP complexes strongly potentiated
the transcription of the cyclin D1 promoter (Figure 4).
However, in NIH3T3 cells, H-Ras
V12 results in down-
regulation of CHOP10 expression via post-transcriptional
mechanism involving decrease in mRNA stability (40).
Nucleic Acids Research, 2008, Vol. 36, No. 11 3617Therefore, JDP2 inhibition Ras-mediated transformation
is consistent with JDP2 repression of the Ras–MAPK–Jun
axis independent of its ability to interact with CHOP10
(22). On the other hand, solid tumors suﬀer from nutrient
and glucose deprivation, which results in an ER stress
response that involves the elevation of the CHOP10
expression. ER stress response in human breast carcinoma
cell lines was shown to results in the increase in pro-
angiogenic factors such VEGF and IL-8 production (41).
CHOP10 association with bZIP proteins such as JDP2 and
ATF3 that results in potentiation of transcription, may
provide the molecular basis for the promotion of
angiogenesis. Further research is required to elucidate the
dual role of JDP2 in angiogenesis and oncogenic processes.
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(Babe), JDP2 (JDP2) and CHOP10 (CHOP). Cells were either untreated (lanes 1–3) or treated with 200nM Tg for 6h (lanes 4–6). Nuclear cell lysate
was subjected to 12.5% SDS–PAGE followed by western blotting. The nitrocellulose membrane was probed with antibodies against CHOP10 and
JDP2. The level of a-tubulin serves as loading control. (B) NIH3T3 pBabe vehicle-transfected cells (blue), NIH3T3 cells overexpressing CHOP10
(orange) and NIH3T3 overexpressing JDP2 (light blue) were exposed to the indicated concentrations of Tg for 24h. Cell viability was measured in
triplicate as described in the Materials and methods section. The results represent the mean SEM of three independent experiments. (C) Parental
(squares) CHOP10
 /  (circles) MEF cells stable cell lines expressing the indicated proteins treated with Tg as described in (A) The migration of
a-tubulin, JDP2, CHOP10 and JDP2-CHOP is indicated. (D) Cells were exposed to diﬀerent concentration of Tg for 24h and cell viability was
measured as described in (B) The results represent the mean SEM of three independent experiments. Parental MEF cell lines used: pBabe vehicle-
transfected (blue), JDP2 expressing cells (light blue), JDP2–CHOP expressing cells (yellow). CHOP10
 /  MEF cells used: pBabe vehicle-transfected
(green), JDP2 expressing cells (red) and CHOP10 expressing cells (brown).
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